Skip to content

COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units

COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04433325
Acronym
TOCCIP
Enrollment
37
Registered
2020-06-16
Start date
2020-07-30
Completion date
2020-10-06
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Intensive Care Unit Syndrome

Keywords

Medical transport by train

Brief summary

Since early 2020, France knows a sanitary crisis with a massive influx of COVID-19 patients admitted in Intensive Care Units (ICU). It led to a saturation of the French health system, especially in some geographic areas such as East of France or Paris region. Therefore, authorities decided to transfer some critically ill patients from these crowded ICUs to less busy regional ICUs. it was done for the first time by medical train transportation. Knowing that the investigators lack experience regarding this type of medical evacuation, regarding the high number of transferred patients, with such a logistic effort, the investigators decided to study this phase of the COVID-19 sanitary crisis in order to draw a feedback. So far, there are no data in the literature regarding this topic.

Interventions

None listed

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age \> 18 years * COVID-19 positive patients admitted in Intensive Care Unit between 15/03/2020 and 15/04/2020 * Patients (or legal representative) with no opposition to inclusion in medical research protocol * Regarding case group : Patients transferred from Paris's ICU * Regarding case control group : Patients admitted in ICU with no transfer from Paris

Exclusion criteria

\- \> 18 years under legal protection and patients with liberty restriction

Design outcomes

Primary

MeasureTime frameDescription
number of deathat Intensive Care Units discharge, an average of 1 monthsto evaluate mortality

Secondary

MeasureTime frameDescription
number of infectionsfrom date of admission until Intensive Care Units discharge, assessed up to 1 monthsto evaluate morbidity
number of days of mechanical ventilationfrom date of admission until Intensive Care Units discharge, assessed up to 1 months
number of days of sedationfrom date of admission until Intensive Care Units discharge, assessed up to 1 months
number of days of use of neuromuscular blocking agentsfrom date of admission until Intensive Care Units discharge, assessed up to 1 months
number of days of vasopressor usefrom date of admission until Intensive Care Units discharge, assessed up to 1 months
number of days in Intensive Care Unitsfrom date of admission until Intensive Care Units discharge, assessed up to 1 months
number of days in hospitalfrom date of admission until hospital discharge, assessed up to 1 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORBenoît Painvin

Rennes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026